R K Srivastava, former director general of health services at the...
Category:
Health
Latest
Future Generali India Insurance launches women-health insurance plan
Anup Rau, managing director and CEO, Future Generali India...
Gold nanoparticles can help arrest ageing Experts
"It is known to slow down the collagen depletion and stimulate cell...
Covid treatment or booster Shot? Non-Vaccine aims to boost immunity
Fortunately, there’s another promising option: preventative Covid-19 treatments using monoclonal antibodies. These are lab-made proteins that boost the immune response to infection by binding to particular sites on the SARS-CoV-2 spike protein. The technique was developed over 35 years ago and more recently used against the Ebola virus.
India reports 45,083 new COVID-19 infections, Kerala logs 31,265 cases
Under the nationwide COVID vaccination drive, 63.09 crore vaccine doses have been administered so far.
Sports Minister Anurag Thakur launches Fit India Mobile App on National Sports Day
“We don’t give enough importance to fitness. What we need to devote is just half an hour of our time in a day to fitness. This app is fun and free and anyone can test and monitor their fitness anywhere.”
Global COVID-19 toll surpasses 4.5 million, US daily average for new cases increases
The European Union is set to recommend halting nonessential travel from the US because of the spread of COVID-19, according to The Wall Street Journal. Diplomatic sources told the newspaper on Sunday that a final decision on the issue is expected on Monday.
Pharma industry to surpass $60 bn by FY24: Report
The report expects this faster growth to be driven by the ability of the domestic industry to leverage the opportunities arising from the expiry of the many patented drugs across the globe, ebbing of regulatory risks, adoption of various de-risk strategies from China dependency for key raw materials, increasing PE investments, and strong fundamentals of the industry.
Covid most transmissible 2 days before, 3 days after symptoms appear: Study
“Our results suggest that the timing of exposure relative to primary-case symptoms is important for transmission, and this understanding provides further evidence that rapid testing and quarantine after someone is feeling sick is a critical step to control the epidemic,” Martinez said.
Half of hospitalised Covid patients have persisting symptoms after a year: Lancet study
“Our study is the largest to date to assess the health outcomes of hospitalised COVID-19 survivors after 12 months of becoming ill,” said Professor Bin Cao, from China-Japan Friendship Hospital.
“While most had made a good recovery, health problems persisted in some patients, especially those who had been critically ill during their hospital stay,” Cao said.
India adds 46,759 new COVID-19 infections, Kerala logs 32,801 cases
India administered more than 10 million vaccine doses in the past 24 hours, a national record that Prime Minister Narendra Modi called a “momentous feat” for the country ahead of fears of another surge in infections. India has administered more than 622 million vaccine doses in total, giving at least one dose to more than half of its 944 million adults.This has been achieved through 67,19,042 sessions.
Covid-19 not developed as biological weapon: US intelligence community
The Director of National Intelligence in a report, prepared at the direction of the president, on Friday said SARS-CoV-2 probably emerged and infected humans through an initial small-scale exposure that occurred no later than November 2019 with the first known cluster of COVID-19 cases arising in Wuhan, China in December 2019.
However, there was no unanimity among the intelligence community (IC) on the origins of the coronavirus.
Covid-19’s Delta variant doubles hospitalisation risk, finds study
“Our analysis highlights that in the absence of vaccination, any delta outbreaks will impose a greater burden on healthcare than an alpha epidemic,” said Anne Presanis, one of the study’s lead authors and a senior statistician at Cambridge. “Getting fully vaccinated is crucial for reducing an individual’s risk of symptomatic infection with delta.”